VeinTech is an Australian MedTech company impacting the most common invasive medical procedure on the planet. Our patented ultrasound-based technology addresses the high failure rates of IV insertions whilst meeting the need for clinically effective and easy to adopt solutions.
Since the advent of intravenous cannulas in the 1950’s, clinicians have used subjective judgement through landmark technique (visual and palpation) to estimate the location, quality and suitability of veins to target with a needle for cannulation. 70 years on, high insertion and post-insertion failure rates still plague healthcare due to limitations in the effectiveness of visualizing vein pathways at depth and guidance technologies that require substantial training and are difficult to use, whilst adding cost to healthcare providers. These result in pain and stress for patients, reduced efficiency for clinicians and significant healthcare costs to providers.
When it comes to placing an intravenous device, VeinTech prioritizes what matters most for patients, clinicians and providers. Introducing our unique ultrasound technology, the VeinWise System: a world-first innovation enabling the visualisation of vein pathways at depth, while being incredibly easy to use and highly accessible through portability and cost. This innovation conceptualized and developed by nursing and medical voices empowers any clinicians performing vascular access to provide the best care for their patient, whilst enabling peace of mind for the patient and efficiency for their organizations.
1 Billion
Peripheral IVs placed annually
40%
Average insertion failure rate